Rozenblit M, Mun S, Soulos P, Adelson K, et al. Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy. Breast Cancer Res 2021;23:14.
PMID: 33514405